Publication | Open Access
The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
82
Citations
32
References
2023
Year
The m6A reader YTHDF1 is required for progression of acute myelogenous leukemia and can be targeted with the FDA-approved drug tegaserod to suppress leukemia growth.
| Year | Citations | |
|---|---|---|
Page 1
Page 1